Aurora Cannabis Inc.
Aurora Cannabis Inc. (ACB.TO) Stock Competitors & Peer Comparison
See (ACB.TO) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACB.TO | CA$4.33 | -3.13% | 245.6M | -2.91 | -CA$1.49 | N/A |
| CURA.CN | CA$5.22 | +9.21% | 4.1B | -6.07 | -CA$0.86 | N/A |
| BHC.TO | CA$7.02 | +0.43% | 2.6B | 12.10 | CA$0.58 | N/A |
| VRNO.CN | CA$6.32 | +6.76% | 2.2B | -5.40 | -CA$1.17 | N/A |
| CURA.TO | CA$2.64 | -4.69% | 2B | -6.00 | -CA$0.44 | N/A |
| GTII.CN | CA$7.87 | -1.62% | 1.8B | 11.92 | CA$0.66 | N/A |
| CRON.TO | CA$3.40 | -2.30% | 1.3B | -113.33 | -CA$0.03 | N/A |
| TRUL.CN | CA$7.05 | -4.73% | 1.2B | -8.81 | -CA$0.80 | N/A |
| TLRY.TO | CA$8.35 | -5.11% | 845.4M | -0.26 | -CA$32.51 | N/A |
| TER.CN | CA$2.38 | -0.42% | 804.8M | -1.33 | -CA$1.79 | N/A |
Stock Comparison
ACB.TO vs CURA.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CURA.CN trades at CA$5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CURA.CN's ROE of -0.28%. Regarding short-term risk, ACB.TO is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CURA.CN's competition here
ACB.TO vs BHC.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BHC.TO has a market cap of 2.6B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BHC.TO trades at CA$7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BHC.TO's P/E ratio is 12.10. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BHC.TO's ROE of -0.20%. Regarding short-term risk, ACB.TO is more volatile compared to BHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check BHC.TO's competition here
ACB.TO vs VRNO.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, VRNO.CN has a market cap of 2.2B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while VRNO.CN trades at CA$6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, ACB.TO's ROE is -0.01%, compared to VRNO.CN's ROE of -0.30%. Regarding short-term risk, ACB.TO is less volatile compared to VRNO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check VRNO.CN's competition here
ACB.TO vs CURA.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CURA.TO has a market cap of 2B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CURA.TO trades at CA$2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CURA.TO's P/E ratio is -6.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CURA.TO's ROE of -0.30%. Regarding short-term risk, ACB.TO is less volatile compared to CURA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CURA.TO's competition here
ACB.TO vs GTII.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, GTII.CN has a market cap of 1.8B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while GTII.CN trades at CA$7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas GTII.CN's P/E ratio is 11.92. In terms of profitability, ACB.TO's ROE is -0.01%, compared to GTII.CN's ROE of +0.06%. Regarding short-term risk, ACB.TO is less volatile compared to GTII.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check GTII.CN's competition here
ACB.TO vs CRON.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CRON.TO has a market cap of 1.3B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CRON.TO trades at CA$3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CRON.TO's P/E ratio is -113.33. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CRON.TO's ROE of -0.01%. Regarding short-term risk, ACB.TO is more volatile compared to CRON.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CRON.TO's competition here
ACB.TO vs TRUL.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TRUL.CN has a market cap of 1.2B. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TRUL.CN trades at CA$7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TRUL.CN's P/E ratio is -8.81. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TRUL.CN's ROE of -0.10%. Regarding short-term risk, ACB.TO is less volatile compared to TRUL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check TRUL.CN's competition here
ACB.TO vs TLRY.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TLRY.TO has a market cap of 845.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TLRY.TO trades at CA$8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TLRY.TO's P/E ratio is -0.26. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TLRY.TO's ROE of -1.06%. Regarding short-term risk, ACB.TO is less volatile compared to TLRY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check TLRY.TO's competition here
ACB.TO vs TER.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TER.CN has a market cap of 804.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TER.CN trades at CA$2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TER.CN's ROE of -0.73%. Regarding short-term risk, ACB.TO is more volatile compared to TER.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check TER.CN's competition here
ACB.TO vs GUD.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, GUD.TO has a market cap of 724.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while GUD.TO trades at CA$7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas GUD.TO's P/E ratio is -146.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to GUD.TO's ROE of -0.01%. Regarding short-term risk, ACB.TO is more volatile compared to GUD.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check GUD.TO's competition here
ACB.TO vs DHT-U.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, DHT-U.TO has a market cap of 674.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while DHT-U.TO trades at CA$12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas DHT-U.TO's P/E ratio is -13.46. In terms of profitability, ACB.TO's ROE is -0.01%, compared to DHT-U.TO's ROE of -0.11%. Regarding short-term risk, ACB.TO is more volatile compared to DHT-U.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check DHT-U.TO's competition here
ACB.TO vs DHT-UN.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, DHT-UN.TO has a market cap of 596.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while DHT-UN.TO trades at CA$15.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas DHT-UN.TO's P/E ratio is -12.60. In terms of profitability, ACB.TO's ROE is -0.01%, compared to DHT-UN.TO's ROE of -0.11%. Regarding short-term risk, ACB.TO is more volatile compared to DHT-UN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check DHT-UN.TO's competition here
ACB.TO vs VRNO.NE Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, VRNO.NE has a market cap of 479.5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while VRNO.NE trades at CA$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas VRNO.NE's P/E ratio is -1.35. In terms of profitability, ACB.TO's ROE is -0.01%, compared to VRNO.NE's ROE of -0.30%. Regarding short-term risk, ACB.TO is less volatile compared to VRNO.NE. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check VRNO.NE's competition here
ACB.TO vs CPH.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CPH.TO has a market cap of 465.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CPH.TO trades at CA$18.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CPH.TO's P/E ratio is 12.65. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CPH.TO's ROE of +0.24%. Regarding short-term risk, ACB.TO is less volatile compared to CPH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CPH.TO's competition here
ACB.TO vs CCHW.NE Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CCHW.NE has a market cap of 407.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CCHW.NE trades at CA$1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CCHW.NE's P/E ratio is -3.52. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CCHW.NE's ROE of -1.07%. Regarding short-term risk, ACB.TO is less volatile compared to CCHW.NE. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CCHW.NE's competition here
ACB.TO vs CL.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CL.CN has a market cap of 370.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CL.CN trades at CA$1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CL.CN's P/E ratio is -2.08. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CL.CN's ROE of -0.32%. Regarding short-term risk, ACB.TO is less volatile compared to CL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CL.CN's competition here
ACB.TO vs OGI.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, OGI.TO has a market cap of 238.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while OGI.TO trades at CA$1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas OGI.TO's P/E ratio is 11.67. In terms of profitability, ACB.TO's ROE is -0.01%, compared to OGI.TO's ROE of +0.05%. Regarding short-term risk, ACB.TO is less volatile compared to OGI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check OGI.TO's competition here
ACB.TO vs CCHW.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CCHW.CN has a market cap of 228.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CCHW.CN trades at CA$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CCHW.CN's ROE of -1.08%. Regarding short-term risk, ACB.TO is more volatile compared to CCHW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CCHW.CN's competition here
ACB.TO vs TSND.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TSND.TO has a market cap of 228.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TSND.TO trades at CA$0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TSND.TO's P/E ratio is -5.29. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TSND.TO's ROE of -0.73%. Regarding short-term risk, ACB.TO is less volatile compared to TSND.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check TSND.TO's competition here
ACB.TO vs WEED.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, WEED.TO has a market cap of 218.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while WEED.TO trades at CA$1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas WEED.TO's P/E ratio is -0.65. In terms of profitability, ACB.TO's ROE is -0.01%, compared to WEED.TO's ROE of -0.53%. Regarding short-term risk, ACB.TO is less volatile compared to WEED.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check WEED.TO's competition here
ACB.TO vs TH.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TH.TO has a market cap of 205.5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TH.TO trades at CA$4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TH.TO's P/E ratio is -17.19. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TH.TO's ROE of +0.47%. Regarding short-term risk, ACB.TO is more volatile compared to TH.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check TH.TO's competition here
ACB.TO vs CRDL.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CRDL.TO has a market cap of 191M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CRDL.TO trades at CA$1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CRDL.TO's P/E ratio is -4.17. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CRDL.TO's ROE of -2.18%. Regarding short-term risk, ACB.TO is less volatile compared to CRDL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CRDL.TO's competition here
ACB.TO vs XLY.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, XLY.TO has a market cap of 175.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while XLY.TO trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas XLY.TO's P/E ratio is 4.33. In terms of profitability, ACB.TO's ROE is -0.01%, compared to XLY.TO's ROE of +0.27%. Regarding short-term risk, ACB.TO is less volatile compared to XLY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check XLY.TO's competition here
ACB.TO vs CWEB.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CWEB.TO has a market cap of 141.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CWEB.TO trades at CA$0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CWEB.TO's P/E ratio is -4.68. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CWEB.TO's ROE of -1.20%. Regarding short-term risk, ACB.TO is less volatile compared to CWEB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CWEB.TO's competition here
ACB.TO vs BHSC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BHSC.CN has a market cap of 137.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BHSC.CN trades at CA$7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BHSC.CN's ROE of -2.06%. Regarding short-term risk, ACB.TO is more volatile compared to BHSC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check BHSC.CN's competition here
ACB.TO vs HLS.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, HLS.TO has a market cap of 136.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while HLS.TO trades at CA$4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas HLS.TO's P/E ratio is -8.09. In terms of profitability, ACB.TO's ROE is -0.01%, compared to HLS.TO's ROE of -0.19%. Regarding short-term risk, ACB.TO is more volatile compared to HLS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check HLS.TO's competition here
ACB.TO vs JUSH.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, JUSH.CN has a market cap of 120M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while JUSH.CN trades at CA$0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas JUSH.CN's P/E ratio is -1.33. In terms of profitability, ACB.TO's ROE is -0.01%, compared to JUSH.CN's ROE of +0.89%. Regarding short-term risk, ACB.TO is less volatile compared to JUSH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check JUSH.CN's competition here
ACB.TO vs GRIN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, GRIN.CN has a market cap of 97.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while GRIN.CN trades at CA$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas GRIN.CN's P/E ratio is 9.75. In terms of profitability, ACB.TO's ROE is -0.01%, compared to GRIN.CN's ROE of +0.28%. Regarding short-term risk, ACB.TO is less volatile compared to GRIN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check GRIN.CN's competition here
ACB.TO vs MDP.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MDP.TO has a market cap of 94.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MDP.TO trades at CA$3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MDP.TO's P/E ratio is -97.33. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MDP.TO's ROE of -0.00%. Regarding short-term risk, ACB.TO is less volatile compared to MDP.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check MDP.TO's competition here
ACB.TO vs GDNS.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, GDNS.CN has a market cap of 91M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while GDNS.CN trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, ACB.TO's ROE is -0.01%, compared to GDNS.CN's ROE of -0.46%. Regarding short-term risk, ACB.TO is more volatile compared to GDNS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check GDNS.CN's competition here
ACB.TO vs TGOD.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TGOD.CN has a market cap of 62.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TGOD.CN trades at CA$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TGOD.CN's ROE of -0.90%. Regarding short-term risk, ACB.TO is more volatile compared to TGOD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check TGOD.CN's competition here
ACB.TO vs PLTH.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, PLTH.CN has a market cap of 60.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while PLTH.CN trades at CA$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas PLTH.CN's P/E ratio is -0.66. In terms of profitability, ACB.TO's ROE is -0.01%, compared to PLTH.CN's ROE of -0.81%. Regarding short-term risk, ACB.TO is less volatile compared to PLTH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check PLTH.CN's competition here
ACB.TO vs BNXT.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BNXT.CN has a market cap of 57.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BNXT.CN trades at CA$0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BNXT.CN's P/E ratio is -9.40. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BNXT.CN's ROE of +0.77%. Regarding short-term risk, ACB.TO is more volatile compared to BNXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check BNXT.CN's competition here
ACB.TO vs VEXT.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, VEXT.CN has a market cap of 57M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while VEXT.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas VEXT.CN's P/E ratio is -2.30. In terms of profitability, ACB.TO's ROE is -0.01%, compared to VEXT.CN's ROE of -0.23%. Regarding short-term risk, ACB.TO is more volatile compared to VEXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check VEXT.CN's competition here
ACB.TO vs STEM.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, STEM.CN has a market cap of 53.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while STEM.CN trades at CA$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas STEM.CN's P/E ratio is -0.11. In terms of profitability, ACB.TO's ROE is -0.01%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, ACB.TO is more volatile compared to STEM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check STEM.CN's competition here
ACB.TO vs LEEF.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, LEEF.CN has a market cap of 42.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while LEEF.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas LEEF.CN's P/E ratio is -2.09. In terms of profitability, ACB.TO's ROE is -0.01%, compared to LEEF.CN's ROE of +1.64%. Regarding short-term risk, ACB.TO is less volatile compared to LEEF.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check LEEF.CN's competition here
ACB.TO vs MRMD.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MRMD.CN has a market cap of 39.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MRMD.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MRMD.CN's P/E ratio is -1.67. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MRMD.CN's ROE of -0.25%. Regarding short-term risk, ACB.TO is less volatile compared to MRMD.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check MRMD.CN's competition here
ACB.TO vs HEXO.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, HEXO.TO has a market cap of 38.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while HEXO.TO trades at CA$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, ACB.TO's ROE is -0.01%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, ACB.TO is less volatile compared to HEXO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check HEXO.TO's competition here
ACB.TO vs CHM.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CHM.CN has a market cap of 37.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CHM.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CHM.CN's ROE of +0.78%. Regarding short-term risk, ACB.TO is more volatile compared to CHM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CHM.CN's competition here
ACB.TO vs CXXI.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CXXI.CN has a market cap of 36.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CXXI.CN trades at CA$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CXXI.CN's P/E ratio is -7.75. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CXXI.CN's ROE of -0.12%. Regarding short-term risk, ACB.TO is less volatile compared to CXXI.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check CXXI.CN's competition here
ACB.TO vs IAN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, IAN.CN has a market cap of 34.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while IAN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas IAN.CN's P/E ratio is 0.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to IAN.CN's ROE of +0.50%. Regarding short-term risk, ACB.TO is more volatile compared to IAN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check IAN.CN's competition here
ACB.TO vs INNO.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, INNO.CN has a market cap of 29.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while INNO.CN trades at CA$6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas INNO.CN's P/E ratio is -5.78. In terms of profitability, ACB.TO's ROE is -0.01%, compared to INNO.CN's ROE of -0.72%. Regarding short-term risk, ACB.TO is more volatile compared to INNO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check INNO.CN's competition here
ACB.TO vs MVMD.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MVMD.CN has a market cap of 28.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MVMD.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MVMD.CN's P/E ratio is -4.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MVMD.CN's ROE of -4.61%. Regarding short-term risk, ACB.TO is less volatile compared to MVMD.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check MVMD.CN's competition here
ACB.TO vs MMEN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MMEN.CN has a market cap of 27.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MMEN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, ACB.TO is less volatile compared to MMEN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check MMEN.CN's competition here
ACB.TO vs LABS.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, LABS.TO has a market cap of 27.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while LABS.TO trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas LABS.TO's P/E ratio is -2.17. In terms of profitability, ACB.TO's ROE is -0.01%, compared to LABS.TO's ROE of -0.20%. Regarding short-term risk, ACB.TO is less volatile compared to LABS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check LABS.TO's competition here
ACB.TO vs YOUR.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, YOUR.CN has a market cap of 22.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while YOUR.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, ACB.TO is more volatile compared to YOUR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check YOUR.CN's competition here
ACB.TO vs GWAY.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, GWAY.CN has a market cap of 22.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while GWAY.CN trades at CA$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas GWAY.CN's P/E ratio is -17.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to GWAY.CN's ROE of -0.02%. Regarding short-term risk, ACB.TO is more volatile compared to GWAY.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check GWAY.CN's competition here
ACB.TO vs MYCO.NE Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MYCO.NE has a market cap of 21.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MYCO.NE trades at CA$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MYCO.NE's P/E ratio is -0.54. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MYCO.NE's ROE of -0.01%. Regarding short-term risk, ACB.TO is more volatile compared to MYCO.NE. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check MYCO.NE's competition here
ACB.TO vs EPIC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, EPIC.CN has a market cap of 20.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while EPIC.CN trades at CA$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas EPIC.CN's P/E ratio is 8.75. In terms of profitability, ACB.TO's ROE is -0.01%, compared to EPIC.CN's ROE of +0.02%. Regarding short-term risk, ACB.TO is more volatile compared to EPIC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check EPIC.CN's competition here
ACB.TO vs VIN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, VIN.CN has a market cap of 20.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while VIN.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, ACB.TO's ROE is -0.01%, compared to VIN.CN's ROE of -0.79%. Regarding short-term risk, Volatility data is not available for a full comparison. ACB.TO has daily volatility of 5.22 and VIN.CN has daily volatility of N/A.Check VIN.CN's competition here
ACB.TO vs AVCN.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, AVCN.TO has a market cap of 18.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while AVCN.TO trades at CA$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas AVCN.TO's P/E ratio is -15.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to AVCN.TO's ROE of -0.68%. Regarding short-term risk, ACB.TO is less volatile compared to AVCN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check AVCN.TO's competition here
ACB.TO vs AYR-A.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, AYR-A.CN has a market cap of 18.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while AYR-A.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas AYR-A.CN's P/E ratio is -0.03. In terms of profitability, ACB.TO's ROE is -0.01%, compared to AYR-A.CN's ROE of -0.65%. Regarding short-term risk, ACB.TO is less volatile compared to AYR-A.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check AYR-A.CN's competition here
ACB.TO vs CBST.NE Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CBST.NE has a market cap of 17.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CBST.NE trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CBST.NE's P/E ratio is -0.07. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CBST.NE's ROE of +1.89%. Regarding short-term risk, ACB.TO is more volatile compared to CBST.NE. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CBST.NE's competition here
ACB.TO vs IMCC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, IMCC.CN has a market cap of 17.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while IMCC.CN trades at CA$5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas IMCC.CN's P/E ratio is -2.68. In terms of profitability, ACB.TO's ROE is -0.01%, compared to IMCC.CN's ROE of -0.41%. Regarding short-term risk, ACB.TO is less volatile compared to IMCC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check IMCC.CN's competition here
ACB.TO vs MRV.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MRV.TO has a market cap of 15.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MRV.TO trades at CA$1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MRV.TO's P/E ratio is -19.29. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MRV.TO's ROE of N/A. Regarding short-term risk, ACB.TO is more volatile compared to MRV.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check MRV.TO's competition here
ACB.TO vs RVV.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, RVV.CN has a market cap of 15.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while RVV.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas RVV.CN's P/E ratio is -1.17. In terms of profitability, ACB.TO's ROE is -0.01%, compared to RVV.CN's ROE of +9.00%. Regarding short-term risk, ACB.TO is more volatile compared to RVV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check RVV.CN's competition here
ACB.TO vs EXM.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, EXM.CN has a market cap of 15.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while EXM.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, ACB.TO's ROE is -0.01%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, ACB.TO is more volatile compared to EXM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check EXM.CN's competition here
ACB.TO vs PWR.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, PWR.CN has a market cap of 15M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while PWR.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas PWR.CN's P/E ratio is 5.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to PWR.CN's ROE of -0.81%. Regarding short-term risk, ACB.TO is more volatile compared to PWR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check PWR.CN's competition here
ACB.TO vs CHAL.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CHAL.CN has a market cap of 14.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CHAL.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, ACB.TO is more volatile compared to CHAL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CHAL.CN's competition here
ACB.TO vs CTX.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CTX.TO has a market cap of 14M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CTX.TO trades at CA$0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CTX.TO's P/E ratio is 37.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CTX.TO's ROE of +0.03%. Regarding short-term risk, ACB.TO is more volatile compared to CTX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CTX.TO's competition here
ACB.TO vs RIV.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, RIV.CN has a market cap of 13.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while RIV.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, ACB.TO's ROE is -0.01%, compared to RIV.CN's ROE of -0.49%. Regarding short-term risk, ACB.TO is more volatile compared to RIV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check RIV.CN's competition here
ACB.TO vs LOBE.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, LOBE.CN has a market cap of 13.5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while LOBE.CN trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas LOBE.CN's P/E ratio is -1.75. In terms of profitability, ACB.TO's ROE is -0.01%, compared to LOBE.CN's ROE of +3.96%. Regarding short-term risk, ACB.TO is less volatile compared to LOBE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check LOBE.CN's competition here
ACB.TO vs ORI.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, ORI.CN has a market cap of 11.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while ORI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, ACB.TO's ROE is -0.01%, compared to ORI.CN's ROE of +0.09%. Regarding short-term risk, ACB.TO is more volatile compared to ORI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check ORI.CN's competition here
ACB.TO vs BBM.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BBM.CN has a market cap of 9.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BBM.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BBM.CN's P/E ratio is -2.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BBM.CN's ROE of -1.67%. Regarding short-term risk, ACB.TO is less volatile compared to BBM.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check BBM.CN's competition here
ACB.TO vs CNFA.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CNFA.CN has a market cap of 9.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CNFA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, ACB.TO is more volatile compared to CNFA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CNFA.CN's competition here
ACB.TO vs OILS.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, OILS.CN has a market cap of 9.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while OILS.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas OILS.CN's P/E ratio is 5.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to OILS.CN's ROE of -0.08%. Regarding short-term risk, ACB.TO is more volatile compared to OILS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check OILS.CN's competition here
ACB.TO vs VIVO.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, VIVO.TO has a market cap of 9.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while VIVO.TO trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, ACB.TO's ROE is -0.01%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, ACB.TO is less volatile compared to VIVO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check VIVO.TO's competition here
ACB.TO vs CLSH.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CLSH.CN has a market cap of 8.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CLSH.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CLSH.CN's P/E ratio is 3.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CLSH.CN's ROE of +0.03%. Regarding short-term risk, ACB.TO is more volatile compared to CLSH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CLSH.CN's competition here
ACB.TO vs AH.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, AH.TO has a market cap of 8.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while AH.TO trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, ACB.TO's ROE is -0.01%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, ACB.TO is less volatile compared to AH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check AH.TO's competition here
ACB.TO vs AVNT.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, AVNT.TO has a market cap of 7.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while AVNT.TO trades at CA$0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas AVNT.TO's P/E ratio is -0.78. In terms of profitability, ACB.TO's ROE is -0.01%, compared to AVNT.TO's ROE of -0.35%. Regarding short-term risk, ACB.TO is more volatile compared to AVNT.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check AVNT.TO's competition here
ACB.TO vs AUSA.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, AUSA.CN has a market cap of 7.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while AUSA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas AUSA.CN's P/E ratio is -0.11. In terms of profitability, ACB.TO's ROE is -0.01%, compared to AUSA.CN's ROE of -1.15%. Regarding short-term risk, ACB.TO is more volatile compared to AUSA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check AUSA.CN's competition here
ACB.TO vs STHZ.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, STHZ.CN has a market cap of 7.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while STHZ.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, ACB.TO's ROE is -0.01%, compared to STHZ.CN's ROE of +0.36%. Regarding short-term risk, ACB.TO is more volatile compared to STHZ.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check STHZ.CN's competition here
ACB.TO vs MOJO.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MOJO.CN has a market cap of 7.5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MOJO.CN trades at CA$0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MOJO.CN's P/E ratio is -5.36. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MOJO.CN's ROE of -1.22%. Regarding short-term risk, ACB.TO is more volatile compared to MOJO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check MOJO.CN's competition here
ACB.TO vs TRIP.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TRIP.CN has a market cap of 7.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TRIP.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TRIP.CN's P/E ratio is -1.75. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TRIP.CN's ROE of -0.30%. Regarding short-term risk, ACB.TO is less volatile compared to TRIP.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check TRIP.CN's competition here
ACB.TO vs CLC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CLC.CN has a market cap of 7.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CLC.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CLC.CN's P/E ratio is 3.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CLC.CN's ROE of +0.08%. Regarding short-term risk, ACB.TO is more volatile compared to CLC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CLC.CN's competition here
ACB.TO vs SPR.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, SPR.CN has a market cap of 7.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while SPR.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas SPR.CN's P/E ratio is -0.40. In terms of profitability, ACB.TO's ROE is -0.01%, compared to SPR.CN's ROE of +18.75%. Regarding short-term risk, ACB.TO is more volatile compared to SPR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check SPR.CN's competition here
ACB.TO vs RWB.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, RWB.CN has a market cap of 7.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while RWB.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas RWB.CN's P/E ratio is -0.14. In terms of profitability, ACB.TO's ROE is -0.01%, compared to RWB.CN's ROE of +0.23%. Regarding short-term risk, ACB.TO is more volatile compared to RWB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check RWB.CN's competition here
ACB.TO vs HASH.V Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, HASH.V has a market cap of 6.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while HASH.V trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas HASH.V's P/E ratio is 1.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to HASH.V's ROE of +0.14%. Regarding short-term risk, ACB.TO is less volatile compared to HASH.V. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check HASH.V's competition here
ACB.TO vs SE.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, SE.CN has a market cap of 6.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while SE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas SE.CN's P/E ratio is 2.43. In terms of profitability, ACB.TO's ROE is -0.01%, compared to SE.CN's ROE of -73.98%. Regarding short-term risk, ACB.TO is more volatile compared to SE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check SE.CN's competition here
ACB.TO vs SNN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, SNN.CN has a market cap of 6.1M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while SNN.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas SNN.CN's P/E ratio is -0.15. In terms of profitability, ACB.TO's ROE is -0.01%, compared to SNN.CN's ROE of -0.49%. Regarding short-term risk, ACB.TO is more volatile compared to SNN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check SNN.CN's competition here
ACB.TO vs WLLW.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, WLLW.TO has a market cap of 5.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while WLLW.TO trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas WLLW.TO's P/E ratio is -0.22. In terms of profitability, ACB.TO's ROE is -0.01%, compared to WLLW.TO's ROE of -0.30%. Regarding short-term risk, ACB.TO is less volatile compared to WLLW.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check WLLW.TO's competition here
ACB.TO vs BCBC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BCBC.CN has a market cap of 5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BCBC.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BCBC.CN's ROE of -1.93%. Regarding short-term risk, ACB.TO is less volatile compared to BCBC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check BCBC.CN's competition here
ACB.TO vs TGIF.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TGIF.CN has a market cap of 5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TGIF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TGIF.CN's P/E ratio is -0.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TGIF.CN's ROE of -0.12%. Regarding short-term risk, ACB.TO is more volatile compared to TGIF.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check TGIF.CN's competition here
ACB.TO vs CANN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CANN.CN has a market cap of 4.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CANN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CANN.CN's P/E ratio is -0.25. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, ACB.TO is more volatile compared to CANN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CANN.CN's competition here
ACB.TO vs BHNG.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BHNG.CN has a market cap of 4.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BHNG.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BHNG.CN's P/E ratio is -1.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BHNG.CN's ROE of +4.01%. Regarding short-term risk, ACB.TO is more volatile compared to BHNG.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check BHNG.CN's competition here
ACB.TO vs FFNT.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, FFNT.CN has a market cap of 4.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while FFNT.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, ACB.TO's ROE is -0.01%, compared to FFNT.CN's ROE of +7.89%. Regarding short-term risk, ACB.TO is more volatile compared to FFNT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check FFNT.CN's competition here
ACB.TO vs LUFF.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, LUFF.CN has a market cap of 4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while LUFF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, ACB.TO's ROE is -0.01%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. ACB.TO has daily volatility of 5.22 and LUFF.CN has daily volatility of N/A.Check LUFF.CN's competition here
ACB.TO vs FH.NE Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, FH.NE has a market cap of 3.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while FH.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas FH.NE's P/E ratio is -0.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to FH.NE's ROE of -2.83%. Regarding short-term risk, ACB.TO is less volatile compared to FH.NE. This indicates potentially lower risk in terms of short-term price fluctuations for ACB.TO.Check FH.NE's competition here
ACB.TO vs BAMM.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, BAMM.CN has a market cap of 3.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while BAMM.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas BAMM.CN's P/E ratio is -0.12. In terms of profitability, ACB.TO's ROE is -0.01%, compared to BAMM.CN's ROE of +65.27%. Regarding short-term risk, ACB.TO is more volatile compared to BAMM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check BAMM.CN's competition here
ACB.TO vs TILT.NE Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, TILT.NE has a market cap of 3.5M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while TILT.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, ACB.TO's ROE is -0.01%, compared to TILT.NE's ROE of +2.18%. Regarding short-term risk, ACB.TO is more volatile compared to TILT.NE. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check TILT.NE's competition here
ACB.TO vs RMC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, RMC.CN has a market cap of 3.4M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while RMC.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to RMC.CN's ROE of +1.25%. Regarding short-term risk, ACB.TO is more volatile compared to RMC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check RMC.CN's competition here
ACB.TO vs THC.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, THC.CN has a market cap of 3.3M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while THC.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas THC.CN's P/E ratio is -1.00. In terms of profitability, ACB.TO's ROE is -0.01%, compared to THC.CN's ROE of -0.37%. Regarding short-term risk, ACB.TO is more volatile compared to THC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check THC.CN's competition here
ACB.TO vs NBUD.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, NBUD.CN has a market cap of 3.2M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while NBUD.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, ACB.TO's ROE is -0.01%, compared to NBUD.CN's ROE of -0.27%. Regarding short-term risk, ACB.TO is more volatile compared to NBUD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check NBUD.CN's competition here
ACB.TO vs MSVN.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, MSVN.CN has a market cap of 2.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while MSVN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, ACB.TO's ROE is -0.01%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, ACB.TO is more volatile compared to MSVN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check MSVN.CN's competition here
ACB.TO vs AREV.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, AREV.CN has a market cap of 2.9M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while AREV.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas AREV.CN's P/E ratio is -2.25. In terms of profitability, ACB.TO's ROE is -0.01%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, ACB.TO is more volatile compared to AREV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check AREV.CN's competition here
ACB.TO vs ASP.TO Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, ASP.TO has a market cap of 2.8M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while ASP.TO trades at CA$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, ACB.TO's ROE is -0.01%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, ACB.TO is more volatile compared to ASP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check ASP.TO's competition here
ACB.TO vs CDVA.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CDVA.CN has a market cap of 2.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CDVA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CDVA.CN's P/E ratio is -1.25. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CDVA.CN's ROE of +0.50%. Regarding short-term risk, ACB.TO is more volatile compared to CDVA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CDVA.CN's competition here
ACB.TO vs CFT.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, CFT.CN has a market cap of 2.7M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while CFT.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, ACB.TO's ROE is -0.01%, compared to CFT.CN's ROE of -2.12%. Regarding short-term risk, ACB.TO is more volatile compared to CFT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check CFT.CN's competition here
ACB.TO vs IPOT.CN Comparison April 2026
ACB.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACB.TO stands at 245.6M. In comparison, IPOT.CN has a market cap of 2.6M. Regarding current trading prices, ACB.TO is priced at CA$4.33, while IPOT.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACB.TO currently has a P/E ratio of -2.91, whereas IPOT.CN's P/E ratio is -0.50. In terms of profitability, ACB.TO's ROE is -0.01%, compared to IPOT.CN's ROE of -2.22%. Regarding short-term risk, ACB.TO is more volatile compared to IPOT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.TO.Check IPOT.CN's competition here